1. Home
  2. ASYS vs MAIA Comparison

ASYS vs MAIA Comparison

Compare ASYS & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$12.98

Market Cap

164.5M

Sector

Technology

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.53

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
MAIA
Founded
1981
2018
Country
United States
United States
Employees
N/A
13
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
89.7M
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
ASYS
MAIA
Price
$12.98
$1.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
171.8K
1.1M
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.53
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$1,278.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.87
52 Week High
$18.59
$3.19

Technical Indicators

Market Signals
Indicator
ASYS
MAIA
Relative Strength Index (RSI) 48.02 38.48
Support Level $11.60 $1.20
Resistance Level $13.26 $1.66
Average True Range (ATR) 0.79 0.16
MACD 0.06 -0.05
Stochastic Oscillator 47.20 13.43

Price Performance

Historical Comparison
ASYS
MAIA

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: